Inovio soars 225% pre-market on FDA accelerated approval and $80.4 million court award
Investing.com · · AI-summarised by FinFlash
Inovio Pharmaceuticals jumped 225.4% in pre-open trading to Approval transforms Inovio into a commercial-stage company and pressures rival Precigen. Watch launch pricing, payer coverage and any equity raise after the surge. Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.So What?
Understand the context